-
Functional Areas
- Audit and Investigations
-
Capacity development and transition, strengthening systems for health
- A Strategic Approach to Capacity Development
- Capacity Development and Transition - Lessons Learned
- Capacity development and Transition Planning Process
- Capacity Development and Transition
- Capacity Development Objectives and Transition Milestones
- Capacity Development Results - Evidence From Country Experiences
- Functional Capacities
- Interim Principal Recipient of Global Fund Grants
- Legal and Policy Enabling Environment
- Overview
- Resilience and Sustainability
- Transition
-
Financial Management
- CCM Funding
- Grant Closure
- Grant Implementation
- Grant-Making and Signing
- Grant Reporting
- Import duties and VAT / sales tax
- Overview
- Sub-recipient Management
-
Grant closure
- Overview
-
Steps of Grant Closure Process
- 1. Global Fund Notification Letter 'Guidance on Grant Closure'
- 2. Preparation and Submission of Grant Close-Out Plan and Budget
- 3. Global Fund Approval of Grant Close-Out Plan
- 4. Implementation of Close-Out Plan and Completion of Final Global Fund Requirements (Grant Closure Period)
- 5. Operational Closure of Project
- 6. Financial Closure of Project
- 7. Documentation of Grant Closure with Global Fund Grant Closure Letter
- Terminology and Scenarios for Grant Closure Process
- Human resources
- Human rights, key populations and gender
-
Legal Framework
- Agreements with Sub-recipients
- Agreements with Sub-sub-recipients
- Amending Legal Agreements
- Implementation Letters and Performance Letters
- Language of the Grant Agreement and other Legal Instruments
- Legal Framework for Other UNDP Support Roles
- Other Legal and Implementation Considerations
- Overview
- Project Document
- Signing Legal Agreements and Requests for Disbursement
-
The Grant Agreement
- Grant Confirmation: Conditions Precedent (CP)
- Grant Confirmation: Conditions
- Grant Confirmation: Face Sheet
- Grant Confirmation: Schedule 1, Integrated Grant Description
- Grant Confirmation: Schedule 1, Performance Framework
- Grant Confirmation: Schedule 1, Summary Budget
- Grant Confirmation: Special Conditions (SCs)
- Grant Confirmation
- UNDP-Global Fund Grant Regulations
-
Monitoring and Evaluation
- Differentiation Approach
- Monitoring and Evaluation Components of Funding Request
- M&E Components of Grant Implementation
- Monitoring and Evaluation Components of Grant Making
- Overview
- Principal Recipient Start-Up
-
Health Product Management
- Compliance with the Global Fund requirements
- Distribution
- Inspection and Receipt
- International freight, transit requirements and use of INCOTERMS
- Inventory Management
- Overview - Health Product Management
- Pharmacovigilance
- Product Selection
- Quality monitoring of health products
- Quantification and Forecasting
- Rational use
- Risk Management for PSM of health products
-
Sourcing and regulatory aspects
- Development of List of Health Products
- Development of the Health Procurement Action Plan (HPAP)
- Global Health Procurement Center (GHPC)
- Guidance on donations of health products
- Health Procurement Architecture
- Local Procurement of health products
- Other Elements of the UNDP Procurement Architecture
- Procurement of non-pharmaceutical Health Products
- Procurement of Pharmaceutical Products
- Submission of GHPC CO Procurement Request Form
- Storage
- Supply Planning of Health Products
- UNDP Health PSM Roster
- Waste management
- Grant Reporting
-
Risk Management
- Introduction to Risk Management
- Overview
- Risk management in crisis settings
-
Risk Management in the Global Fund
- Additional Safeguard Policy
- Challenging Operating Environment (COE) Policy
- Global Fund Review of Risk Management During Grant Implementation
- Global Fund Risk Management Framework
- Global Fund Risk Management Requirements During Funding Request
- Global Fund Risk Management Requirements for PRs
- Local Fund Agent
- Risk management in UNDP
- Risk Management in UNDP-managed Global Fund projects
- UNDP Risk Management Process
- Sub-Recipient Management
Key considerations for indicator selection
When developing a Performance Framework, please:
1) Ensure that the selected indicators are:
- relevant to the type of the epidemic and aligned with the national programme priorities and interventions supported by the grants;
- appropriate for measuring the goals and objectives of the programme;
-
selected from the core list, including the following:
- impact and outcome
- coverage of population receiving services
- quality (for example, attrition rate on ART, treatment success rate for TB, External Quality Assessment (EQA) of labs)
- gender, and
- equity (disaggregation by target population/target area)
- appropriate for monitoring progress of impact, outcome and coverage at national level (in some cases, these may be reported at subnational or project level);
- relevant to the target groups being reached by the grant;
- supported by adequate systems for the collecting and reporting of high-quality data, or by M&E system strengthening investment to enable such reporting;
- ideally, the selected indicators should be captured in the national M&E Plan.
2) Identify indicators for which disaggregated data will be required (at the time of results reporting) to assess equity across various age and sex groups and the key populations. NEW in GC7: disaggregated results reporting will be expected only once a year (in NFM3/GC6 the High-Impact and Core Countries reported disaggregated results each semester).
3) Check the capacity for data collection, reporting and analysis and identify any need for system strengthening / technical assistance.
- Indicators with no related M&E system in place should be supported by a clear plan and adequate budget to develop the required system.
- If baselines and denominators are not available, propose an action plan to the Global Fund Country Team for collecting these; the plan should include clear timeframes.
Note that process and input indicators are not included in the Performance Framework.
![](/images/icons/ic-light.png)
NEW in GC7 Funding Cycle
Under GC7, the inclusion of coverage indicators is prioritized by groups. The following prioritization guidance should be used by non-COE countries when selecting indicators into the Performance Framework.
- Group 1 - Selected HIV, TB, malaria, RSSH and Equity, Human Rights and Gender (EHRG) KPIs and indicators critical for monitoring success of the Global Fund strategy - to be included in all grants. Must have for modules supported by the grant with possibility to "opt-out” i.e. If a "Group 1" indicator is not included in the Performance Framework, the PHME/Country Teams will need to explain the rationale in the Grant Making Final Review Form (GMFRF).
- Group 2 - Indicators essential for monitoring implementation of key disease and RSSH interventions - at least 1-2 to be included per module as applicable to the grant.
- Group 3 - Indicators specific to a particular context or for routine grant monitoring – advised to be included as per relevance and relative funding for these specific modules/interventions.
- Inclusion of Equity, Human Rights and Gender (EHRG) indicators is mandatory.
- Priority in selecting indicators should be given to Group 1, followed by Group 2 indicators. IMPORTANT: All indicators once included in the Performance Framework are of equal value. Classification as Group 2 or 3 does not make the indicator non-essential or less important during grant performance assessment.
![](/images/icons/ic-light.png)
In the selection of Group 3 indicators the criteria of relevance and relative funding is used. Thus, if a country is undertaking an important initiative/intervention (in line with its NSP) and the budget is deemed considerable*, then a group 3 indicator needs to be included. Example: If Indoor Residual Spraying (IRS) is one of the strategies of malaria prevention in the NSP and if the intervention has meaningful budgets from the GF, then the CCM can propose the inclusion of the Group 3 indicator "Proportion of population at risk receiving at least one round of IRS within the last 12 months in areas targeted for IRS"
*There is no predefined budget threshold and indicators should be selected based on relevance to the grant.![](/images/icons/ic-light.png)
Based on a holistic set of criteria including allocation size, allocation focus, in-country capacities and political context, in consultation with in-country and Global Fund stakeholders, each Focused portfolio is designated a specific model type.
There are four model types – Aligned, Targeted, Light and Legacy. Each type is described in-depth on the Global Fund webpage on Focused portfolio management models. The Allocation Letter informs Focused portfolios of their model for the 2023-2025 Period.
Focused country models 1 (Aligned) and 2 (Targeted) - Required indicators selected based on Payment for Results (PfR) objectives to be measured. The indicator prioritization guidance does not apply.
Focused country models 3 (Light) and 4 (Legacy) - Recommended to include "Group 1" indicators with possibility to opt out. Additional indicators may be included as applicable.
![](/images/icons/ic-light.png)
In the NFM3/GC6 funding cycle, for Focused portfolios, it was recommended to have a limited number of indicators in Performance Framework (e.g., 1-5 impact/outcome and 3-5 coverage indicators, approximately 6-8 in total) covering only the key program area/modules supported by the grant. Please note that in GC7 this is no longer the case – there is no longer an upper ceiling for a number of indicators in the Performance Framework. It is the indicator grouping that drives prioritisation.
Loading resources
![](/images/spinner.gif)